Besides, CD13 was highly expressed around the tumor vessels and the tumor tissue from IFN-α2a-NGR treatment group showed weak staining, whereas those from IFN-α2a treatment groups showed stronger staining with anti-CD13 antibody and control groups showed strongest staining (Figure S2). This evidence concerns the gene RTN4R and neoplasm.